All posts by imreal

PICMG® Releases Its Newest COM.0 R3.1 Spec for COM Express to Include PCIe Gen 4 and USB 4.0 Support


ExpressBASE6 R3.1-F

Summary:

  • COM.0 R3.1 adds support for PCIe Gen 4, for all module types, while adding USB4 support for Type 6 and updating 10G Ethernet to support CEI side-band signaling plus adding a second PCIe Clock for Type 7
  • R3.1 compliant, ADLINK provides two new modules, along with out-of-the-box ready development kits
  • Express-ADP Type 6 Basic size: powered by 12th Gen Intel® Core™ supporting advanced hybrid architecture with up to 6 Performance-cores (P-cores) and 8 Efficient-cores (E-cores) at 15W/28W/45W TDP
  • Express-ID7 Type 7 Basic size: powered by Intel® Xeon® D-1700 featuring integrated high-speed Ethernet for up to 4x 10G combined with 16 PCIe Gen4 lanes for instantaneous responsiveness and performance

ADLINK Technology Inc., a global leader in edge computing and a chair of the PICMG® subcommittee, is pleased to demonstrate PICMG’s latest COM.0 R3.1 with two new COM Express modules complying to the revision — ADLINK’s Express ADP Type 6 Basic size and Express-ID7 Type 7 Basic size.

Compared to R3.0, Revision 3.1 has added support for several advanced interfaces suitable for next-gen AIoT applications, such as PCIe Gen 4 support across all module types, USB4 for Type 6 and adding a second PCIe Clock while updating 10G Ethernet to support CEI side-band signaling for Type 7. Other enhancements include adding options for general purpose SPI, MIPI-CSI connectors, and SoundWire, as well as adding IPMB for Type 7.

R3.1 compliant, ADLINK’s Express-ADP Type 6 Basic size and Express-ID7 Type 7 Basic size modules are respectively powered by 12th Gen Intel® Core™ and Intel® Xeon® D-1700 processors.

ADLINK Express-ADP Type 6 Basic size utilizes 12th Gen Intel® Core™ processors based on advanced hybrid architecture with up to 6 Performance-cores (P-cores) and 8 Efficient-cores (E-cores), effectively boosting productivity and fueling IoT innovation across a wide variety of deployments. It provides DDR5 memory support with up to 4800 MT/s combined with increased cache, and integrated Intel® Iris® Xe graphics with up to 96EUs, to offer four concurrent 4K60 HDR displays and Intel® Deep Learning Boost for superior AI performance. Using DDI, eDP 1.4b and USB4/TBT4, the four independent displays support Display Alternative mode, the module provides premium graphics features for superior content support, display and I/O virtualization.

ADLINK Express-ID7 Type 7 Basic size, based on Intel® Xeon® D-1700 processor, features integrated high-speed Ethernet for up to 4x 10G combined with 16 PCIe Gen4 lanes for instantaneous responsiveness and performance. Built for rugged and edge AI applications, this ADLINK COM with Intel® Ice Lake-D empowers system integrators to realize all of their IoT innovations, from edge networking, unmanned aerial vehicles, autonomous driving, robotic surgery, to rugged HPC servers, 5G base stations, automatic drilling, ship management, and more.

For immediate application-specific development, ADLINK will also have out-of-the-box-ready development kits with the abovementioned COM.0 R3.1 modules. Developers can seek further details about these dev kits from ADLINK’s I-Pi wiki website. In addition, for convenient reference testing, ADLINK offers carrier boards — Express-BASE6 R3.1 and Express-BASE 7 R3.1 — and bundled starter kits, available on ADLINK’s website.

Visit ADLINK Technology to learn more about these COM.0 R3.1 modules.

About ADLINK Technology

ADLINK Technology Inc. (TAIEX:6166) leads edge computing, the catalyst for a world powered by artificial intelligence. ADLINK manufactures edge hardware and develops edge software for embedded, distributed, and intelligent computing – from powering medical PCs in the intensive care unit to building the world’s first high-speed autonomous race car – more than 1600 customers around the world trust ADLINK for mission-critical success. ADLINK holds top-tier edge partnerships with Intel, NVIDIA, AWS, and SAS, and also participates on the Intel Board of Advisors, ROS 2 Technical Steering Committee and Autoware Foundation Board. ADLINK contributes to open source, robotics, autonomous, IoT and 5G standards initiatives across 24+ consortiums, driving innovation in manufacturing, telecommunications, healthcare, energy, defense, transportation and infotainment. For over 25 years, with 1800+ ADLINKers and 200+ partners, ADLINK enables the technologies of today and tomorrow, advancing technology and society around the world. Follow ADLINK Technology on LinkedIn, Twitter, Facebook or visit adlinktech.com.

Share article on social media or email:

JPMA Receives 2022 Power of Associations Silver Award for JPMA Cares


News Image

“JPMA members represent 95 percent of the baby and children’s products industry in North America, and we are dedicated to advancing the health and safety of babies and young children,” said Executive Director of JPMA and JPMA Cares Lisa Trofe.

The Juvenile Products Manufacturers Association (JPMA) earned a Power of Associations Silver Award from the American Society of Association Executives (ASAE) for its successful JPMA Cares initiative.

Founded in 2021 by JPMA, JPMA Cares is a charitable organization that contributes to the long-term success of babies and young children by reducing barriers to healthy development, ensuring fundamental needs are met, and promoting a safe and nurturing environment to learn and grow.

The organization works to improve outcomes for all children and is intentional about meeting the needs of babies and young children. For some, the need is products or education, but for others, fundamental needs like housing, food and basic medical care are not being met. As JPMA Cares secures the right resources, the organization partners with like-minded charities to distribute these resources to people and places in high need. JPMA Cares has partnered with the Injury Free Coalition for Kids on its annual National Injury Prevention Day; Cradles to Crayons; Family Promise; and the United Nations Foundation to name a few.

“Congratulations to JPMA and JPMA Cares for exemplifying the impact associations have on the industries and professions they represent, and on society at large,” said ASAE President and CEO Michelle Mason, FASAE, CAE. “It’s always so incredibly satisfying to see associations going above and beyond their everyday mission to change the world. We’re very proud to spotlight this award-winning initiative.”

“On behalf of our Board of Directors, staff, donors and volunteers, we appreciate this recognition of JPMA Cares from the American Society of Association Executives,” said Executive Director of JPMA and JPMA Cares Lisa Trofe. “JPMA members represent 95 percent of the baby and children’s products industry in North America, and we are dedicated to advancing the health and safety of babies and young children. JPMA Cares believes that thriving babies make for a better world.”

JPMA Cares will host its second annual Benefit for Babies on Thursday, December 1, 2022 from 6:30-9:30 p.m. ET at SPIN New York 54, 7 East 54th Street, New York, NY 10022. The event is open to anyone interested in advancing long-term outcomes for babies and children in need. Participants will enjoy networking, food, drinks, music, a silent auction and the opportunity to play ping pong in a unique and vibrant setting. Tickets can be purchased by visiting https://jpmacares.app.neoncrm.com/np/clients/jpmacares/eventRegistration.jsp?event=4&.

For additional ways to get involved with JPMA Cares, please visit jpmacares.org.

About JPMA Cares

JPMA Cares contributes to the long-term success of babies and young children by reducing barriers to healthy development, ensuring fundamental needs are met, and promoting a safe and nurturing environment for them to learn and grow. JPMA Cares is a 501(c)(3) charitable organization, founded by JPMA (the Juvenile Products Manufacturers Association) and supported by the broader baby and children’s products industry. Learn more at https://jpmacares.org.

About The Power of Associations Awards

ASAE’s Power of Associations Awards recognize the associations’ economic and societal contributions locally, nationally and globally. The Power of Associations Awards reward outstanding initiatives in five categories: Industry/Professional Advancement, Community Support and Engagement, Global Development, Diversity and Inclusion and Advocacy. ASAE will celebrate The Power of Associations Award winners during its annual Summit Awards Dinner on September 29, 2022, at the National Building Museum in Washington, D.C.

Share article on social media or email:

Remedy Institute Resumes Groundbreaking Study of MDMA-Assisted Therapy for the Treatment of PTSD


Remedy Institute Logo

Remedy Institute

We’re excited to continue this critical research, and are glad to have been able to work collaboratively with Health Canada to ensure we are meeting the absolute highest procedural standards.

Remedy Institute, a newly launched charity with a focus on innovation in mental health, is resuming its clinical trial of MDMA and Cognitive Processing Therapy (CPT) to treat PTSD following Health Canada’s review of the study.

“We’re excited to continue this critical research, and are glad to have been able to work collaboratively with Health Canada to ensure we are meeting the absolute highest procedural standards. We are proud to be demonstrating that we can do this research in a small charitable organization, creating an innovative and sustainable model for psychedelic research,” said founder Dr. Anne Wagner.

Few clinical research trials undergo the Health Canada inspection and review process. With Health Canada’s approval to resume the study, Remedy Institute is able to return to providing excellent participant care.

MDMA has demonstrated tremendous therapeutic potential for the treatment of PTSD and is an area of increasing interest in clinical research around the world, with potential to dramatically improve treatment outcomes for the millions of people suffering from the disorder.

As a leader in the field of psychedelic-assisted treatment for PTSD, clinical psychologist and founder Dr. Anne Wagner created Remedy as a home for research and practice in 2018. The clinic began operations with a team of five, and has now grown to over 30 clinicians and staff, including psychologists, social workers, and researchers.

Remedy Institute was launched in March 2022 with a mandate to raise funds for and conduct cutting-edge research, while simultaneously reducing barriers to mental health services. The launch of Remedy Institute marks the next step in the Remedy ecosystem’s drive to innovate mental health services and research.

Alongside the innovative research taking place at Remedy Institute, the charity offers a bursary program for those facing barriers in accessing mental health services. The Bursary Program provides funding for focused, short-term treatment courses, with an emphasis on BIPOC, 2SLGBTQ+, and artist communities.

About Remedy Institute

Remedy Institute is a registered charity that conducts innovative research into new treatment modalities and provides access to mental health care services for people facing financial barriers to accessing treatment. For more information please visit https://remedyinstitute.ca.

Media Contact

Eric Sorenson, Communications Manager

press@remedycentre.ca

Share article on social media or email:

ClinOne to Showcase Adaptive Experiences in Clinical Trials and Share How They Drive Patient Compliance and Retention at Key Industry Conferences and Events


News Image

It’s important to hear from research sites, patients and caregivers, and meet with the sponsors and CROs shaping the future of clinical trials at events that connect people who want to learn from and partner together to make a difference for patients. -ClinOne Marketing VP Kristopher Sarajian

ClinOne, the leading provider of Adaptive Experiences for clinical trials, will participate in discussions, share best practices and lessons learned, and showcase its proven solutions for consent management, patient ride, HCP trial awareness, medication adherence, site engagement, TeleVisits, and more.

You can connect with ClinOne at the following industry conferences and events:

October

—SCRS Global Site Solutions Summit, Hollywood FL, October 7-9 (Alliance Sponsor)

—Outsourcing In Clinical Trials New England 2022, Boston, MA, October 12-13 (Sponsor and Exhibitor)

—Outsourcing In Clinical Trials & Clinical Supply Nordics 2022, Scandic Copenhagen, October 25-26

November

—CNS Summit 2022, Boca Raton, November 17-20 (Sponsor and Exhibitor)

“ClinOne is a technology provider in an industry that researches and develops life-changing biopharmaceutical products – and yet at our core, we are all part of a people business,” said Kristopher Sarajian, VP of Marketing at ClinOne (LinkedIn). “There is simply no substitute for hearing firsthand from research sites what the past three years have been like, experiencing patient and caregiver stories, or meeting with the study sponsors and CROs who are shaping the future of clinical trials. As 2022 has gone on, we’re excited to get back to what conferences and events do best – connecting people who are eager to learn from each other and partner together to make a difference for patients and families worldwide.”

To see how Adaptive Experiences can improve patient compliance and retention in your next clinical trial, schedule a demo at http://www.clinone.com.

About ClinOne

ClinOne is the leading provider of Adaptive Experiences for clinical trials. By offering choice to patients, caregivers, and site staff, our technology makes it easier to stay active, compliant, and comfortable in a trial – thereby expanding enrollment access, reducing drop-out rate, and shortening conduct timelines. Our true single platform features solutions for local HCP trial awareness, remote and onsite eConsent, Uber Health, medication adherence, and a DCT portal. ClinOne stands alone with the industry’s fastest implementation (average 2-6 weeks), cost-efficient scale, and seamless API integrations for complex therapeutic areas such as Oncology, CNS, and Rare Disease in over 60 languages. To learn why more than 55 sponsors and CROs trust ClinOne in 100+ currently active studies to connect, inform, and empower participants to take control of their clinical trial experience, begin a conversation with our experts at http://www.clinone.com.

Share article on social media or email:

Internationally Recognized Breast Medical Oncologist Shares Stories of Support for Metastatic Breast Cancer Patients


News Image

Dr. Charles L Vogel uses his 44 years of experience as an internationally-recognized opinion leader in breast cancer treatment and research to write “Living with Metastatic Breast Cancer.” His radiation oncology colleague, Dr. Laura Freedman, provides valuable insights throughout the book.

Dr. Vogel is a board-certified breast medical oncologist, specializing in breast cancer treatment and prevention. He’s received the United States Public Health Service Commendation medal for his work in Uganda, was awarded the “Legend in Cancer Care” award, and the Lifetime Achievement Award at the Greater Miami Chamber of Commerce’s “Health Care Heroes” award ceremony in 2019.

Through this book, Drs. Vogel and Freedman offer support and encouragement. They present real, inspirational clinical histories specifically for patients with MBC.

“Receiving a Metastatic Breast Cancer (MBC) diagnosis is a life changing event,” Dr. Vogel said. “MBC is treatable, but not curable, and many focus on the word ‘incurable’. They become concerned that they will miss big life events or major milestones in loved one’s lives.”

Dr. Vogel’s book describes the clinical courses of 40 people living with MBC, often many years beyond what statistics would predict. There are stories of coping, courage, adaptation, prolonged survivals, true grit, and occasional miracles. After reading this book, Vogel and Freedman hope that readers will gain optimism and persevere, feeling that they too can beat the statistics.

“I see it all the time,” Dr. Vogel explains “Once a patient receives the diagnosis, they worry about seeing children graduate, seeing loved ones get married. I want to show them that, even with an MBC diagnosis, it is possible to live a long, happy life.”

“Living With Metastatic Breast Cancer: Stories of Hope and Faith”

By Charles L. Vogel, MD & Laura M Freedman, MD

ISBN: 9781669815396 (softcover); 9781669815389 (electronic)

Available at Xlibris, Amazon and Barnes & Noble

About the author

Charles L. Vogel, M.D., F.A.C.P., trained at Princeton, Yale Medical school, Emory, and the US National Cancer Institute (NCI). in 1975 he became the first Chief of the Breast Cancer Division and, ultimately a tenured full professor and clinical director of the University of Miami (Florida) Comprehensive Cancer Center. After leaving the University he pioneered breast cancer clinical research from within private practice settings. Over the past three decades he has: become a nationally and internationally recognized breast cancer key opinion leader; published over 500 manuscripts and abstracts; and participated in clinical trials leading to commercial availability of most of the breast cancer therapeutics in use today. He currently practices breast medical oncology at the Baptist Health Miami Cancer Institute/Plantation, FL.

Laura M Freedman, M.D., completed medical school at the University of Michigan and trained in Radiation Oncology at MD Anderson Cancer Center in Houston, Texas. She began her career at Wayne State University and the Karmanos Cancer Institute. She joined faculty at the University of Michigan before joining Sylvester Comprehensive Cancer Center in 2011. She is currently the Director of Radiation Oncology at the Deerfield Beach location and an Associate Professor of the University of Miami Miller School of Medicine. Over the past two decades she has published articles focused on education and has been involved in multiple national committees for the field of Radiation Oncology. She is currently a boards examiner for the American Board of Radiology.

###

General Inquiries:            

LAVIDGE – Phoenix                        

Ashley Fletcher

afletcher@lavidge.com

Share article on social media or email:

Well Hidden in the 21st Century” is a fascinating look at the historical context of modern theology


News Image

“The Reformation: Well Hidden in the 21st Century”: an articulate and encouraging approach to returning to God’s Word. “The Reformation: Well Hidden in the 21st Century” is the creation of published author Dr. Ken Matto, a New Jersey native who holds a doctorate degree in ministry from Bethany Theological Seminary in Dothan, Alabama.

Dr. Matto shares, “Jesus stated in John 8:32, ‘And ye shall know the truth, and the truth shall make you free.’ The truth of Scripture is to set the Christian free; yet as soon as one becomes saved, they place themselves back into slavery under a theological system.

“This book is written with the desire to see the Christian emancipated from theological slavery and become a Biblicist, thus setting them free from the boundaries found in every theological system. The local church becomes a local prison in that unless one adheres to the warden’s (the pastor’s) teachings, then one will be shown the door. Brethren, these things should not be. The King James Bible opens the cell doors and frees the Christian from their theological imprisonment.”

Published by Christian Faith Publishing, Dr. Ken Matto’s new book will challenge and engage the spirit as readers consider the carefully studied and detailed points within.

Dr. Matto shares in hopes of aiding others to break free of what he terms “theological slavery” so they can achieve a renewed connection with the Word of God.

Consumers can purchase “The Reformation: Well Hidden in the 21st Century” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “The Reformation: Well Hidden in the 21st Century,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

New book provides inspiration and roadmap to help you take back your power, move forward and ‘Be Your Own Miracle’


News Image

New release “Be Your Own Miracle” (published by Balboa Press AU) from Kathryn Mills is a spiritual guidebook that shares insights on overcoming and healing from cancer and defeating life’s challenges by activating one’s inner power, intuition and divine connection.

In this book, the author details how she healed herself of stage 4 brain cancer after being given months to live as well as the protocols she used to strengthen her mindset, change her perspective and fuel her faith. She also shares how she tapped into her intuition, opened her mind to alternative therapies, and reconnected with the Divine Creator. It is Mills’ hope that by sharing her story, others who are going through stress, loss, adversity and illness will be inspired to shift their perspective and move from victim to self-empowerment.

An excerpt from the book reads:

Victory begins in the dark. The power that is going to save you is coming from the inside. Deep inside of you. We all have this ability. It just needs to be turned on. Throughout this book, you are going to either find it or strengthen it. Or both. If I can do it, you can too. It’s time to BE YOUR OWN MIRACLE.

To know more and get a copy, visit https://www.balboapress.com/en-au/bookstore/bookdetails/839307-be-your-own-miracle.

“Be Your Own Miracle”

By Kathryn Mills

Softcover | 6 x 9in | 256 pages | ISBN 9781982295097

E-Book | 256 pages | ISBN 9781982295103

Available at Amazon and Barnes & Noble

About the Author

Kathryn Mills is a board certified holistic health coach who specializes in integrative wellness and lifestyle mentoring, with over 25 years in the health and wellness field. She is an advocate for chemical-free and low tox living and is a proud mother of one gorgeous, divine daughter. Her profound passion for the metaphysical, combined with her infectious, bold personality, and ability for educating and motivating others on how to live a healthier lifestyle, flows through her words in a down-to-earth manner. Mills’ ability to share her knowledge and life experience through writing, is similar to a modern day mix of Carrie Bradshaw meets Gabby Bernstein. Her health background was further honed by her long-held role as a senior sleep health consultant selling registered Class 1 Medical Sleep Systems for 16 years. During this time, she has helped thousands of people by educating them on the importance and value of sleep and prioritizing their physical bodies and lifestyle. Her deep level of compassion and empathy, coupled with her extensive knowledge, gave those she encountered a proven tangible solution, coupled with clear answers and understanding. Mills is a true “Earth Angel,” and through her own major life crisis, is here to guide and heal those facing similar challenges around health, particularly cancer, and improving people’s lifestyles. She hopes to lift, inspire and teach others how to overcome your current challenges and circumstances, and remind them that every day truly is a gift and another day to be grateful for. For more information on Mills’ work, visit http://www.KathrynsJourney.com.

Balboa Press Australia is a division of Hay House, Inc., a leading provider in publishing products that specialise in self-help and the mind, body and spirit genre. Through an alliance with the worldwide self-publishing leader Author Solutions, LLC, authors benefit from the leadership of Hay House Publishing and the speed-to-market advantages of the Author Solutions self-publishing model. For more information or to start publishing today, visit balboapress.com.au or call 1-800-844-925.

Share article on social media or email:

FDA Approves First ALS Treatment Funded by Ice Bucket Challenge


Donations form the 2014 social media phenomenon known as the Ice Bucket Challenge funded a new treatment for ALS that was just approved by the FDA

American Airlines employees in St. Louis take part in the 2014 ALS Ice Bucket Challenge, which led to $115 million in donations for the ALS Association

“We thank the millions of people who donated and participated in the Ice Bucket Challenge, enabling us to invest in promising therapies like AMX0035 that will immediately help people living with ALS,” said Calaneet Balas, president and CEO of the ALS Association.

FDA Approves First ALS Treatment Funded by Ice Bucket Challenge

ALS Association Invested $2.2 Million Raised by Grassroots Social Media Movement into Development and Trial of AMX0035

The ALS Association, the country’s largest nonprofit committed to making ALS livable and finding a cure, today celebrated the Food and Drug Administration’s (FDA) approval of AMX0035, a new treatment for people living with amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease. The Association invested $2.2 million of funds raised through the 2014 ALS Ice Bucket Challenge into the development and trial of AMX0035, and led the years-long advocacy campaign that pushed the FDA to approve the treatment prior to completion of an ongoing phase 3 trial.

“We thank the millions of people who donated and participated in the Ice Bucket Challenge, enabling us to invest in promising therapies like AMX0035 that will immediately help people living with ALS,” said Calaneet Balas, president and CEO of the ALS Association. “This is a victory for the entire ALS community, which came together to advocate for early approval of AMX0035. We still have a lot of work to do to cure ALS, but this new treatment is a significant step in that fight.”

Added Balas: “We are thinking of Pat Quinn and Pete Frates, who championed the Ice Bucket Challenge and changed the trajectory of ALS forever.”

In June of 2016, the Association provided Amylyx, the producer of AMX0035, with a $750,000 grant for a clinical trial pilot, and in July of 2016, the Association provided the Northeast ALS Consortium (NEALS) with a $1.46 million grant to help pay for the phase 2 clinical trial of AMX0035. The Association has also provided regulatory, medical, and research counsel to help expedite the progress of AMX0035.

In September of 2020, The ALS Association and I AM ALS submitted over 50,000 signatures to the FDA calling on the agency to approve AMX0035. In subsequent months, the Association held multiple meetings with FDA officials, including a public We Can’t Wait Action Meeting in May of 2021, so members of the ALS community could speak directly to FDA officials. The Association also provided scientific and regulatory guidance and in 2022, drove over 14,000 individual emails to the FDA urging approval.

“It’s hard to put into words how significant this approval is for the thousands of Americans who are living with ALS and their families,” said Larry Falivena, a member of the ALS Association Board of Trustees who was diagnosed with ALS in 2017. “The ALS community has proven that our advocacy can impact decisions that are being made about our health. We need new treatments as quickly as possible if we are going to turn ALS into a livable disease and eventually cure it.”

In the summer of 2014, over 17 million people posted Ice Bucket Challenge videos to Facebook, including hundreds of celebrities, athletes, and politicians. The campaign, which was popularized by Pat Quinn and Pete Frates, two young men who were living with ALS, raised over $115 million for the ALS Association. Frates passed away in 2019 and Quinn passed away in 2020.

Balas said: “The approval of AMX0035 is further proof of how the Ice Bucket Challenge dramatically accelerated the fight against ALS. Since then, we’ve seen new genes discovered, new assistive technology developed to help people living with ALS, and far more people living with ALS have access to care services than ever before.”

Since the Ice Bucket Challenge, the ALS Association has spent over $127 million on ALS research and is currently funding 130 research projects in 12 countries. The Association is currently funding 40 potential treatments in the drug development pipeline.

In addition, the Association has expanded its network of clinical providers from 100 Certified Treatment Centers of Excellence, Recognized Treatment Centers, and Affiliated Clinics in 2014 to 188 today.

In 2019, RTI International, an independent research organization, surveyed ALS researchers about the impact of Ice Bucket Challenge resources. RTI reported 84 percent of respondents said support from the Association since the Challenge accelerated their work quite a bit or very much, while 72 percent of respondents said funding from the Association improved their ability to receive additional funding.

About ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. Over the course of the disease, people lose the ability to move, to speak, and eventually, to breathe. On average, it takes about a year before a final ALS diagnosis is made. The disease is always fatal, usually within five years of diagnosis. There is no cure.

About The ALS Association

The ALS Association is the largest philanthropic funder of ALS research in the world. The Association funds global research collaborations, assists people with ALS and their families through its nationwide network of care and certified clinical care centers, and advocates for better public policies for people with ALS. The ALS Association is working to make ALS a livable disease while urgently searching for new treatments and a cure. For more information about The ALS Association, visit our website at http://www.als.org

CONTACT:

Brian Frederick, Ph.D.

Senior Vice President, Strategic Communications

The ALS Association

202-464-8612

brian.frederick@als.org

Share article on social media or email:

VA Maryland Health Care System Volunteer Achieves National Recognition


Minta Davis, a volunteer at the VA Maryland Health Care System, is the recipient of the first-ever VA Excellence in Customer Experience Volunteer of the Year Award.

“Minta is a tremendous asset to our health care system and the veterans we serve,” said Jonathan R. Eckman, P.E., director of the VA Maryland Health Care System.

Minta Davis, a volunteer at the VA Maryland Health Care System, is the recipient of the first-ever VA Excellence in Customer Experience Volunteer of the Year Award. Davis was selected for this national recognition from 36 nominations submitted by VA medical centers across the country. Her selection was announced at the first annual Customer Experience (CS) Symposium Award Ceremony held on September 7, 2022, in Washington, D.C. Joyce Kuwae, a Voluntary Service Specialist at the Perry Point VA Medical Center, accepted the award from VA Secretary Denis R. McDonough on her behalf.

A retired Air Force veteran, Davis began volunteering at the health care system in 2015. She has contributed nearly 900 hours in multiple roles, most recently serving as a volunteer with the Compassionate Contact Corps (CCC) program. The program—also known as the “Phone Buddy Program”—was established by VA during the COVID-19 pandemic as a way to provide veterans stuck at home and alone with an opportunity to have routine socialization through the telephone. It pairs veterans with designated and specially trained VA volunteers based on mutual interests.

As a volunteer, Minta continually seeks to add to her knowledge and qualifications to enhance the impact she has on the veterans she supports. In the past year she has completed VA suicide prevention training, obtained Mental Health First Aid certification, and completed several webinars on the Compassionate Contact Corps and other volunteer-related topics.

Minta was matched earlier this year with a veteran who requested someone in the CCC program who could encourage him to meet his goals for physical activity and adopting healthier habits. She provides gentle reassurance each week, calling upon her knowledge of VA’s Whole Health principles, her skill as a certified yoga instructor, and her own personal health challenges. Soon after she began speaking with the veteran, he enrolled in a Virtual Tai Chi class and began aiming to reach a daily step count goal. Minta has been instrumental in enabling the veteran to improve his outlook and overall health and well-being.

“Minta is a tremendous asset to our health care system and the veterans we serve,” said Jonathan R. Eckman, P.E., director of the VA Maryland Health Care System. “As a VA volunteer, her positive attitude, outstanding compassion, and unique skill set are a prefect fit with our mission of providing safe, quality and compassionate care to veterans.”

“We are incredibly fortunate and proud to have Minta on our team,” added Susan Kern, program manager for Voluntary Service for the VA Maryland Health Care System. “She is proof that our volunteers—even when serving in a virtual capacity—can have a positive impact on veterans.”

Minta Davis lives in Carroll County.

The VA Maryland Health Care System (VAMHCS) provides a broad spectrum of medical, surgical, rehabilitative, mental health and outpatient care to veterans at three medical centers and five outpatient clinics located throughout the state. More than 52,000 veterans from various generations receive care from VAMHCS annually. Nationally recognized for its state-of-the-art technology and quality patient care, VAMHCS is proud of its reputation as a leader in veterans’ health care, research and education. It costs nothing for veterans to enroll for health care with the VA Maryland Health Care System and it could be one of the more important things a veteran can do. To enroll for VA health care, interested veterans can call 877-222-8387 Monday through Friday from 8 a.m. to 8 p.m., or they can visit http://www.va.gov and clinic on “Apply now for VA health care.”

Share article on social media or email:

The First All-In-One Posture Corrector and Foam Roller, Invented By a Doctor of Physical Therapist For Neck, Shoulder and Back Pain


The patented SOLEX posture roller restores the natural curve of the spine while relieving neck, shoulder and back pain.

The SOLEX Posture Roller is her innovative solution, made to bring the spine back to its natural alignment in just a few minutes of lying down, benefiting the body on many levels.

Dr. Aman Dhaliwal announces the launch of the SOLEX Posture Roller, the first posture corrector and foam roller all-in-one. Developed by California-based physical therapist, Dr. Aman Dhaliwal, the patented roller helps people restore the natural curve in their spines and relieves neck, shoulder and back pain.

According to Dr. Dhaliwal, traditional foam rollers are flat, unlike our curved spines, and are not designed to improve spine health and enhance overall body performance. The SOLEX Posture Roller is her innovative solution, made to bring the spine back to its natural alignment in just a few minutes of lying down, benefiting the body on many levels.

“In my 15 years treating the musculoskeletal system, I’ve seen first hand the frustration from many patients when dealing with spine and other pain issues,” said Dr. Dhaliwal. “I finally decided to take matters into my own hands and design the right type of foam roller, one with curves that mimic the shape of our spines and provide quick relief without the need of unnecessary medication or surgery. It properly corrects postures by connecting to the entire spine and positively impacts our physical and mental well-being.”

Good posture is the first step to good spinal health. Systemic postural issues may account for shoulder/back pain, headaches, breathing restrictions, digestion disorders, poor confidence, and other common ailments.

Dr. Dhaliwal added that spinal disorders might develop as we lose curves with wear and tear over time, reducing the spine’s ability to protect posture and our nerves that control essential bodily functions, such as sleeping, digestion and breathing. By strengthening the core muscles with the SOLEX Posture Roller and restoring the spine’s natural alignment, changes can be felt instantly with added benefits over time.

Lightweight and portable, use the SOLEX Posture Roller daily for two to five minutes to relieve tightness and tension, and help the spine return to its optimal position. This results in better circulation, decreased pain, increased mobility and a reduction in recovery time.

The SOLEX Posture Roller launch price is $129 and will be available on Nov. 1. For more information, visit http://www.getsolex.com.

###

About SOLEX

Find your much-needed pain relief with SOLEX! Their innovative Posture Roller naturally helps your spine realign to its correct position, giving you immediate tension and tightness relief, increased mobility, and a better outlook on life. Don’t suffer through the pain any longer, strengthen your body and restore your health today!

Share article on social media or email: